Možnosti a meze změn struktury psychiatrické péče u nás

MUDr. Ondřej Peč

Psychiatr. pro Praxi, 2008; 9(4): 155  

The treatment of depression in patients with schizophrenia

MUDr. Luboš Janů Ph.D, MUDr. Sylva Racková

Psychiatr. pro Praxi, 2008; 9(4): 160-163  

Many schizophrenic patients use antidepressants. We try to evaluated reasons for this medications and its contribution. Only small number of schizophrenic patients suffering from serious and long-term depression has some benefit from antidepressants. Contrariwise antidepressants may cause or exacerbate some adverse events like extrapyramidal symptoms or sexual dysfunction.

The most frequent causes of agitation at a somatic department

MUDr. Josef Chval

Psychiatr. pro Praxi, 2008; 9(4): 164-165  

In this article I am turning my mind to the most frequent causes of acute agitation with the somatic patients. This is my view of the problem as I have been working as a internist in a mental home. Agitated patients come here from other types of hospitals. Mental deragements accompanied with acute agitation are often caused or increased thanks to patient´s hospitalization. Their somatic problems are complicated then and they basicly influence diagnostics and ways of treatement. They also turn worse the therapy and prognosis. Agitation may run parallely with lots of mental deseases. The most frequent of then are both deliria: of non-alcoholic and alcoholic...

Suicidality in schizophrenia

MUDr. Tomáš Kašpárek Ph.D

Psychiatr. pro Praxi, 2008; 9(4): 166-167  

We review the risk factors of suicidal behavior in schizophrenia, its differential diagnosis as well as treatment and prevention strategies. The main risk factors include depression, hopelessness, early stages of the illness, previous suicidal behavior, and substance abuse. It is more frequent in males, in patients with higher level of cognitive functions and insight. The prevention strategies should focus on the patients in the beginning of the illness, immediately after the discharge, continuity, education, depressive symptomatology. Clozapine is the only psychopharmacological approach with sufficient evidence for its antisuicidal effect.

Theraupeutical approaches of acute agitation and aggression

MUDr. Vlasta Hanušková

Psychiatr. pro Praxi, 2008; 9(4): 168-169  

Acute agitation and aggression may occur as symptoms of many mental disorders, but non-psychiatric causes of agitation are also possible. The primary goal of intervention is to provide safety for patient and other present individuals. Pharmacological treatment is usually necessary to shorten the period of agitation or physical restraint of the patient.

Metabolic syndrome and SELECTED MENTHAL ILLNESSES

doc. MUDr. Miroslav Zeman CSc, doc. MUDr. Roman Jirák CSc

Psychiatr. pro Praxi, 2008; 9(4): 170-173  

Metabolic syndrome, characterized by coincidental occurence of several risk factors of cardiovascular diseases, is connected not only with an increased risk of ischaemic heart disease and other complications of atherosclerosis but also with other diseases such as type 2 diabetes mellitus or some malignancies (e. g. colorectal, prostate or pancreatic cancer). Nowadays, the connection between metabolic syndrome and some neurologic and psychiatric diseases (especially schizophrenia, depressive disorder and Alzheimer´s disease) is disputed. The article outlines the relationship between metabolic syndrome on one hand and selected mental diseases on...

Ze zahraniční literatury

Psychiatr. pro Praxi, 2008; 9(4): 173  

Stimulants in child AND ADOLESCENT OUTPATIENT CARE

doc. MUDr. Libuše Stárková CSc

Psychiatr. pro Praxi, 2008; 9(4): 174-176  

Stimulants represent medicaments of the first choice for the treatment of ADHD in children and adolescents. The caution associated with their prescription has in our country intelligible historical and medical causes. The target of this article is to disperse doubts about this therapy and to encourage psychiatrists to use methylphenidate in ADHD treatment.

Antiepileptic drugs in the treatment of schizophrenia spectrum psychoses

doc. MUDr. Ladislav Hosák Ph.D, prof. MUDr. Jan Libiger CSc

Psychiatr. pro Praxi, 2008; 9(4): 177-180  

Antipsychotics are the first-choice treatment in schizophrenia and related psychoses. Because almost 20 per cent of patients do not respond to antipsychotics alone, combination treatment with antiepileptics is a subject of interest. We review the most recent knowledge in this field based on the mechanism of action of individual antiepileptics. High doses of benzodiazepines may be effective in positive symptoms of schizophrenia, anxiety and agitation. Augmentation of antipsychotics with carbamazepine may be beneficial in violent patients, subjects with affective symptoms and EEG abnormalities. Positive symptoms, irritability, hostility and aggressiveness...

Aripiprazol v léčbě negativních symptomů schizofrenie

MUDr. Tatiana Fabíniová

Psychiatr. pro Praxi, 2008; 9(4): 181  

ROMOVÉ A DUŠEVNÍ NEMOCI

Mgr. Andrea Tibenská

Psychiatr. pro Praxi, 2008; 9(4): 191-192  

12. konference psychosomatické medicíny, 24.-26. dubna 2008, Liberec

Petr Miklas

Psychiatr. pro Praxi, 2008; 9(4): 193  

Sertindol se vrací

MUDr. Klára Látalová Ph.D

Psychiatr. pro Praxi, 2008; 9(4): 185-186  

Substituce opioidových závislostí

MUDr. Jiří Švarc Ph.D

Psychiatr. pro Praxi, 2008; 9(4): 187-190  

Místo psychoterapie v rámci ambulantní psychiatrické péče

MUDr. Jiří Berka

Psychiatr. pro Praxi, 2008; 9(4): 182-183  

6. Sympozium Společnosti pro biologickou psychiatrii

doc. MUDr. Ladislav Hosák Ph.D

Psychiatr. pro Praxi, 2008; 9(4): 194